Evolution of CAR T-cell immunotherapy in terms of patenting activity
- PMID: 30940940
- DOI: 10.1038/s41587-019-0083-5
Evolution of CAR T-cell immunotherapy in terms of patenting activity
References
-
- Kolata, G. New gene-therapy treatments will carry whopping price tags. The New York Times https://www.nytimes.com/2017/09/11/health/cost-gene-therapy-drugs.html (11 September 2017).
-
- Grady, D. Companies rush to develop ‘utterly transformative’ gene therapies. The New York Times https://www.nytimes.com/2017/07/23/health/gene-therapy-cancer.html (23 July 2017).
-
- Sadelain, M. & Rivière, I. CAR T cells in cancer therapy (poster). Nat. Rev. Drug Disc. (December 2017).
-
- Golstein, P. & Griffiths, G. M. Nat. Rev. Immunol. 18, 527–535 (2018). - DOI
-
- Mullard, A. Nat. Rev. Drug Discov. 14, 301 (2015).